Erratum: An experimental model of tennis elbow in rats: A study of the contribution of the nervous system (Inflammation (1998) 22 (435-444) DOI 10.1023/A:1022377001084);An experimental model of tennis elbow in rats: A study of the contribution of the nervous system

Inflammation

Volumn 22, Issue 4, 1998, Pages 435-444

  Haker, Eva ^a   Theodorsson, Elvar ^b   Lundeberg, Thomas ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CARRAGEENAN; FREUND ADJUVANT; NEUROKININ A; NEUROPEPTIDE Y; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; EPICONDYLITIS; IMMUNOREACTIVITY; MALE; NONHUMAN; PLASMA; RAT; SENSORY NERVE; TENNIS ELBOW;

ANIMALIA;

EID: 0031817413     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-009-9133-3     Document Type: Erratum

References (56)

1. ALLENDER, E. 1974. Prevalence, incidence, and remission rates of some common rheumatic diseases or syndromes. Scand. J. Rheumatol. 3:145-153.
2. KIVI, P. 1982. The aetiology and conservative treatment of humeral epicondylitis. Scand J Rehabil. Med. 15:37-41.
3. NIRSCHL, R. P. 1973. Tennis elbow. Orthoped. Clin. North America 4(3):787.
4. HAKER, E. 1993. Lateral epicondylalgia: Diagnosis, treatment and evaluation. Crit Rev Phys Rehabil. Med. 5(2):129-154.
5. HAKER, E., and T. LUNDEBERG. 1990. Acupuncture treatment in epicondylalgia: A comparative study of two acupuncture techniques. Clin. J. Pain 6:221-226.
6. HAKER, E., and LUNDEBERG T. 1993. Elbow band, splintage and steroids in lateral epicondylalgia. Pain Clinic 62:103-112.
7. HAKER, E., and T. LUNDEBERG. 1990. Laser treatment applied to acupuncture points in lateral humeral epicondylalgia. A double-blind study. Pain 43:243-247.
8. HAKER, E., and T. LUNDEBERG. 1991. Is low energy laser treatment effective in lateral epicondylalgia? J. Pain Symptom Management 6(4):241-246.
9. HAKER, E., and T. LUNDEBERG. 1991. Lateral epicondylalgia (tennis elbow): Report of noneffective mid-laser treatment. Arch. Phys. Med. Rehabil. 72(12):984-988.
10. HAKER, E., and T. LUNDEBERG. 1991. Pulsed ultrasound treatment in lateral epicondylalgia. A double-blind study. Scand. J. Rehabil. Med. 23:115-118.
11. BURTON, A. K. 1988. A comparative trial of forearm strap and topical anti-inflammatory as adjunct to manipulative therapy in tennis elbow. Man. Med. 3:141-143.
12. LEHMAN, L. 1974. Therapeutic heat and cold. Clin. Orthoped. Related Research. 99:220-237.
13. DEVEREAUX, M. D., B. L. HAZLEMAN, and P. P. THOMAS. 1985. Chronic lateral humeral epicondylitis - a double blind controlled assessment of pulsed electromagnetic field therapy. Clin. Exp. Rheumatol. 3:333-336.
14. PERCY, E. C., and J. D. CARSON. 1981. The use of DMSO in tennis elbow and rotator cuff tendonitis - a double blind study. Med. Sci. Sports Exercise. 13:215-219.
15. FAMAEY, J. P., G. BROUX, D. CLEPPE, A. DEROULEZ, F. DUCKERTS, and EDVARD, F. et al. 1982. Ionisation with voltaren, A multi-centre trial. J. Belge. Med. Phys. Rehabil. 5(2):55-60.
16. SAARTOK, T., and E. ERIKSSON. 1986. Randomized trial of oral naproxen or local injection of betamethasone in lateral epicondylitis of the humerus. Orthopedics 9(2):191-194.
17. SÖLVEBORN, S. A., and B. BJERKING-DICKMAR. 1990. Stretching as treatment of tennis elbow/radial epicondylalgia. Proc 4th Congress of the European Society for Surgery of the Shoulder and the Elbow, 1990 Oct. Milano.
18. CHARD, M. D., and B. L. HAZLEMAN. 1989. Tennis elbow: a reappraisal. Br J Rheumatol 28:186-190.
19. CHARD, M. D., T. R. CAWSTON, G. P. RILEY, G. A. GRESHAM, and B. L. HAZLEMAN. 1994. Rotatorcuff degeneration and lateral epicondylitis: a comparative histological study. Ann. Rheum. Dis. 53:30-34.
20. NIRSCHL, R. P. 1992. Elbow tendinosis/tennis elbow. Clin. Sports Med. 11(2):851-870.
21. BINDER, A., G. PARR, P. THOMAS, and B. HAZLEMAN. 1983. A clinical and thermography study of lateral epicondylitis. Br. J. Rheumatol. 22:77-81.
22. THOMAS, D., and J. P. SAVAGE. 1989. Persistent tennis elbow: evaluation by infrared and nuclear medicine isotope scanning. Thermology 3:132-136.
23. THOMAS, D., G. SIAHAMIS, M. MILLICENT, and C. BOYLE. 1992. Computerised infrared thermography and isotopic bone scanning in tennis elbow. Ann. Rheum. Dis. 51:103-107.
24. GOLDIE, I. 1964. Epicondylitis lateralis humeri. Acta. Chir. Scand. Suppl 339.
25. BASBAUM, A. I., D. MENETREY, R. PRESLEY, and J. D. LEVINE. 1988. The contribution of the nervous system to experimental arthritis in the rat. Editors. Besson, J. M., and Guibaud. G. In: The Arthritic Rat as a Model of Clinical Pain? Elsevier, Amsterdam. 41-53.
26. HOLSAPPLE, M. P., and G. K. W. YIM. 1983. Therapeutic reduction of ongoing carrageenin-induced inflammation by lipooxygenase, but not cyclooxygenase inhibitors. Inflammation 3:223-230.
27. NEIL, A., J. M. BENOIST, V. KAYSER, and G. GUILBAUD. 1987. Initial nociceptive sensitization in carrageenin-induced rat paw inflammation is dependent on amine autacoid mechanisms: electrophysiological and behavioural evidence obtained with a quaternary antihistamine, thiazinamium. Exp. Brain Res. 65:343-351.
28. DI ROSA, M., J. P. GIROUD, and D. A. WILLOUGHBY. 1971. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol. 104:15-29.
29. GILLARD, G. C., and D. A. LOWTHER. 1976. Carrageenin-induced arthritis. II. Effects of intraarticular injection of carrageenin on the synthesis of perprotoeoglycan in articular cartilage. Arthritis Rheum. 19:918-922.
30. CARMICHAEL D. J., G. C. GILLARD, D. A. LOWTHER, C. J. HANDLEY, and V. B. SANTER. 1977. Carrageenin-induced arthritis. IV. Rate changes in cartilage matrix proteoglycan synthesis. Arthritis Rheum. 20:834-840.
31. LOWTHER, D. A., J. D. SANDY, V. B. SARTER, and H. L. G. BROWN. 1978. Antigen-induced arthritis. Decreased proteoglycan content and inhibition of proteoglycan synthesis in articular cartilage. Arthritis Rheum. 21:675-680.
32. KONTTINEN, Y. T., R. REES, M. HUKKANEN, M. GRÖNBLAD, E. TOLVANEN, S. J. GIBSON, J. M. POLAK, and D. A. BREWERTON. 1990. Nerves in inflammatory synovium: immunohistochemical observations on the adjuvant arthritic rat model. J. Immunol. 17:1586-1591.
33. BILEVICIUTE, I., T. LUNDEBERG, EKBLOM, E. THEODORSSON. 1993. Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptidelike Y-like immunoreactivity in rat joint synovial fluid during acute monoarthritis. Neurosci. Lett. 153:37-40.
34. WEIHE, E., D. NOHR, S. MULLER, M. BUCHLER, H. FRIESS, and H.-J. ZENTEL. 1991. The tachykinin neuroimmune connection in inflammatory pain. Ann. N. Y. Acad. Sci. 632:283-294.
35. SCHAIBLE, H.-G., B. JARROT, P. J. HOPE, and A. W. DUGGAN. 1990. Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat. Brain Res. 529:214-223.
36. HOPE, P. J., B. JARROTT, H.-G. SCHAIBLE, E. W. CLARKE, and A. W. DUGGAN. 1990. Release and spred of immunoreactive neurokinin A in the cat spinal cord in a model of acute arthritis. Brain Res. 533:292-299.
37. LAM, F., and W. R. FERELL. 1989. Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann. Rheum. Dis. 48:928-932.
38. THEDORSSON-NORHEIM, E., A. HEMSEN, E. BRODIN, J. M. LUNDBERG. 1987. Sample handling techniques when analysing regulatory peptides. Life Sci. 41:845-848.
39. BRODIN, E., N. LINDEFORS, C.-J. DALSGAARD, E. THEODORSSON-NORHEIM, and S. ROSELL. 1986. Tachykinin multiplicity in the rat central nervous system as studied using antisera against substance P and neurokinin A. Regul. Pept. 13:253-272.
40. THEODORSSON-NORHEIM, E., R. BRODIN, I. NORHEIM, and S. ROSELL. 1984. Antisera raised against eledosin and kassinin detect immunoreactive material in rat tissue extracts: tissue distribution and chromatographic characterization. Regul. Pept. 9:229-244.
41. THEODORSSON-NORHEIM, E., A. HEMSEN, and J. M. LUNDBERG. 1985. Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand. J. Clin. Lab. Invest. 45:355-365.
42. GAMSE, R., M. POSCH, A. SARIA, and G. JANCSO. 1987. Several mediators appear to interact in neurogenic inflammation. Acta. Physiol. Hung. 69:343-354.
43. BECK, P. W., and H. O. HANDWERKER. 1974. Bradykinin and serotonin effects on various types of cutaneous nerve fibres. Pflugers Arch. 347:209-222.
44. CHAHL, L. A., and A. IGGO. 1977. The effects of bradykinin and prostaglandin E-1 on rat cutaneous afferent nerve activity. Br. J. Pharmacol. 59:343-347.
45. BIRCH, P. J., S.-M. HARRISON, A. G. HAYES, H. ROGERS, and M. B. TYERS. 1992. The non-peptide NK-1 receptor antagonist, (+)-CP -96, 345, produces antinociceptive and anti-oedema effects in the rat. Br. J. Pharmacol. 105:508-510.
46. WOOLF, C. J., and Z. WIESENFELD-HALLIN. 1986. Substance P and calcitonon gene-related peptide synergistically modulate the gain of the nociception reflex in the rat. Neurosci. Lett. 66:226-230.
47. LOUIS, S. M., D. JOHNSTONE, A. J. MILLEST, N. J. W. RUSSELL, and G. J. DOCKRAY. 1990. Immunization with calcitonin gene-related peptide reduces the inflammatory response to adjuvant arthritis in the rat. Neuroscience 39:729-731.
48. SATOH, M., Y. KURAISHI, and M. KAWAMURA. 1992. Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain 49:273-278.
49. THEDORSSON-NORHEIM, E., I. NORHEIM, K. ÖBERG, E. BRODIN, J. M. LUNDBERG, K. TATEMOTO, and P. G. LINDGREN. 1985. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients. Bichem. Biophys. Res. Commu. 131:77-83.
50. GAMSE, R., M. POSCH, A. SARIA, and G. JANCSO. 1987. Several mediators appear to interact in neurogenic inflammation. Acta. Physiol. Hung. 69:343-354.
51. WIMALAWANSA, S. J., and I. MACINTYRE. 1988. Heterogenicity of plasma calcitonin gene-related peptide: partial characterization of immunoreactive forms. Peptides 407-410.
52. EKBLAD, E., L. EDVINSSON, C. WAHLESTEDT, R. UDDMAN, R. HÅKANSSON, and F. SUNDLER. 1984. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul. Pept. 8:225-35.
53. MORRIS, M., V. KAPOOR, and J. CHALMERS. 1987. Plasma neuropeptide Y concentration is increased after hemorrhage in conscious rats: relative contributions of sympathetic nerves and the adrenal medulla. J. Cardiovasc. Dis. 9:541-545.
54. ERDÖS, E. G., and R. A. SKIDGEL. 1989. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptides hormones. FASEB 3:145-151.
55. NADEL, J. A. 1991. Neutral endopeptidase modulates neurogenic inflammation. Eur. Respir. J. 4:745-754.
56. WIMALAWANSA, S. J. 1990. Effects of in vivo stimulation on molecular forms of circulatory calcitonin and calcitonin gene-related peptide in man. Mol. Cell Endocrinol. 71:13-29.